Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.

Gonzalez M, Litzistorf Y, Krueger T, Popeskou SG, Matzinger O, Ris HB, Gronchi F, Lovis A, Peters S.

Ann Thorac Surg. 2013 Jul;96(1):247-52. doi: 10.1016/j.athoracsur.2013.04.009. Epub 2013 May 16.

PMID:
23684158
2.

Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy.

Storelli E, Tutic M, Kestenholz P, Schneiter D, Opitz I, Hillinger S, Weder W.

Eur J Cardiothorac Surg. 2012 Jul;42(1):77-81. doi: 10.1093/ejcts/ezr291. Epub 2012 Jan 20.

PMID:
22290903
3.

The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.

Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.

Ann Thorac Surg. 2009 Sep;88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084.

PMID:
19699925
4.

Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.

Merritt RE, Mathisen DJ, Wain JC, Gaissert HA, Donahue D, Lanuti M, Allan JS, Morse CR, Wright CD.

Ann Thorac Surg. 2009 Nov;88(5):1574-81; discussion 1581-2. doi: 10.1016/j.athoracsur.2009.07.060.

PMID:
19853115
5.

Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.

Yildizeli B, Fadel E, Mussot S, Fabre D, Chataigner O, Dartevelle PG.

Eur J Cardiothorac Surg. 2007 Jan;31(1):95-102. Epub 2006 Nov 28.

PMID:
17126556
6.
7.

Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.

Toyooka S, Soh J, Shien K, Sugimoto S, Yamane M, Oto T, Date H, Miyoshi S.

Eur J Cardiothorac Surg. 2013 Mar;43(3):568-72. doi: 10.1093/ejcts/ezs323. Epub 2012 Jun 1.

PMID:
22659891
8.

Sleeve lobectomy after induction chemoradiotherapy.

Gómez-Caro A, Boada M, Reguart N, Viñolas N, Casas F, Molins L.

Eur J Cardiothorac Surg. 2012 May;41(5):1052-8. doi: 10.1093/ejcts/ezr184. Epub 2012 Jan 4.

PMID:
22223693
9.

Bronchopleural fistula in the surgery of non-small cell lung cancer: incidence, risk factors, and management.

Sirbu H, Busch T, Aleksic I, Schreiner W, Oster O, Dalichau H.

Ann Thorac Cardiovasc Surg. 2001 Dec;7(6):330-6.

PMID:
11888471
10.

Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.

Kasprzyk M, Dyszkiewicz W, Piwkowski C, Brudlo M, Galecki B, Gabryel P, Gasiorowski L.

Neoplasma. 2013;60(1):62-7. doi: 10.4149/neo_2013_009.

PMID:
23067218
11.

Sleeve lobectomy for non-small cell lung cancer.

De Leyn P, Rots W, Deneffe G, Nafteux P, Coosemans W, Van Raemdonck D, Decker G, Lerut T.

Acta Chir Belg. 2003 Nov-Dec;103(6):570-6. Review.

PMID:
14743560
12.

Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer.

Veronesi G, Solli PG, Leo F, D'Aiuto M, Pelosi G, Leon ME, De Braud F, Spaggiari L, Pastorino U.

Lung Cancer. 2002 Apr;36(1):91-7.

PMID:
11891039
13.

Extended sleeve lobectomy: one more step toward avoiding pneumonectomy in centrally located lung cancer.

Berthet JP, Paradela M, Jimenez MJ, Molins L, Gómez-Caro A.

Ann Thorac Surg. 2013 Dec;96(6):1988-97. doi: 10.1016/j.athoracsur.2013.07.011. Epub 2013 Sep 12.

PMID:
24035301
14.

Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.

Perentes J, Bopp S, Krueger T, Gonzalez M, Jayet PY, Lovis A, Matzinger O, Ruffieux C, Ris HB, Letovanec I, Peters S.

Ann Thorac Surg. 2012 Dec;94(6):1815-22. doi: 10.1016/j.athoracsur.2012.08.054. Epub 2012 Oct 25.

PMID:
23103000
15.

Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.

Takeda S, Maeda H, Koma M, Matsubara Y, Sawabata N, Inoue M, Tokunaga T, Ohta M.

Eur J Cardiothorac Surg. 2006 Mar;29(3):276-80. Epub 2006 Jan 24. Review.

PMID:
16434204
16.

[Technique, results and impact of induction chemotherapy in sleeve lobectomy for lung cancer].

Borri A, Leo F, Galetta D, Veronesi G, Solli P, Petrella F, Gasparri R, Scanagatta P, Spaggiari L.

Minerva Chir. 2006 Aug;61(4):307-13. Italian.

PMID:
17122763
17.

Morbidity and mortality after induction chemotherapy followed by surgery in IIIa-N2 non small cell lung cancer.

Borreman P, De Leyn P, Decaluwé H, Moons J, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.

Acta Chir Belg. 2009 May-Jun;109(3):333-9.

PMID:
19943589
18.

Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies.

Suen HC, Meyers BF, Guthrie T, Pohl MS, Sundaresan S, Roper CL, Cooper JD, Patterson GA.

Ann Thorac Surg. 1999 Jun;67(6):1557-62.

PMID:
10391254
19.

Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis.

Cusumano G, Marra A, Lococo F, Margaritora S, Siciliani A, Maurizi G, Poggi C, Hillejan L, Rendina E, Granone P.

Ann Thorac Surg. 2014 Sep;98(3):975-83. doi: 10.1016/j.athoracsur.2014.04.095. Epub 2014 Jul 16.

PMID:
25038013
20.

Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.

Petersen RP, Pham D, Toloza EM, Burfeind WR, Harpole DH Jr, Hanish SI, D'Amico TA.

Ann Thorac Surg. 2006 Jul;82(1):214-8; discussion 219.

PMID:
16798217

Supplemental Content

Support Center